Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-23-009959
Date:2023-01-31
Issuer: SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Original Submission Date:

Reporting Person:

KHATTAR JACK A.
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE ROCKVILLE, MD 20850

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2023-01-31 M 1,620 a $9.56 795,937 direct
COMMON STOCK 2023-01-31 S 976 d $42.01 794,961 direct
COMMON STOCK 2023-01-31 0 $0.00 1,047,700 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 9.56 2023-01-31 deemed execution date M 1,620 (d) 2024-01-23 common stock 1,620 $9.56 48,380 direct
Footnotes
IDfootnote
f1 transaction made pursuant to a 10b5-1 trading plan adopted september 15, 2022.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $42.00 to $42.07, inclusive. the reporting person undertakes to provide to supernus pharmaceuticals, inc. ("supernus"), any security holder of supernus, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this form 4.
f3 the options vested in four equal annual installments beginning on january 23, 2015.
WhaleWisdom Logo

Elevate your investments